A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

Condition	Treatment or Intervention	Phase
Seasonal Affective Disorder (SAD)	Drug: Investigational Seasonal Affective Disorder (SAD) Drug	Phase III

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria: (Patient must meet these criteria in order to be eligible for this study.)

• Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.

Exclusion Criteria: (Patient cannot meet these criteria in order to be eligible for this study.)

• Patient has a current or past history of seizure disorder or brain injury.
• Patient has a history or current diagnosis of anorexia nervousa or bulimia.
• Patient has recurrent summer depression more frequently than winter depression.
• Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
• Patient has initiated psychotherapy within the last 3 months.

Alaska
      Homer,  Alaska,  99603,  United States
Connecticut
      New Haven,  Connecticut,  06504-0605,  United States
Delaware
      Newark,  Delaware,  19713,  United States
      Wilmington,  Delaware,  19808-1251,  United States
District of Columbia
      Washington,  District of Columbia,  20016,  United States
      Washington,  District of Columbia,  20037,  United States
Idaho
      Boise,  Idaho,  83704,  United States
Illinois
      Libertyville,  Illinois,  60048,  United States
      Study SIte, Northfield,  Illinois,  60093,  United States
      Study SIte, Chicago,  Illinois,  60610,  United States
      Schaumburg,  Illinois,  60194,  United States
      Chicago,  Illinois,  60612,  United States
      Hoffman Estates,  Illinois,  60194,  United States
Indiana
      Study SIte, Greenwood,  Indiana,  46143,  United States
      Indianapolis,  Indiana,  45202,  United States
Kentucky
      Florence,  Kentucky,  41042,  United States
Massachusetts
      Wellesley Hills,  Massachusetts,  02481,  United States
Michigan
      Okemos,  Michigan,  48864,  United States
      Royal Oak,  Michigan,  48067,  United States
Minnesota
      Minneapolis,  Minnesota,  55454,  United States
New Jersey
      Piscataway,  New Jersey,  08854,  United States
      Moorestown,  New Jersey,  08057,  United States
New York
      Williamsville,  New York,  14221,  United States
      Lawrence,  New York,  11559,  United States
      New York,  New York,  10021,  United States
      Olean,  New York,  14760,  United States
      Staten Island,  New York,  10305,  United States
      New York,  New York,  10021,  United States
      Amityville,  New York,  11701,  United States
Ohio
      Cleveland,  Ohio,  44121,  United States
      Cleveland,  Ohio,  44106,  United States
      Toledo,  Ohio,  43623,  United States
      Lyndhurst,  Ohio,  44124,  United States
      Cincinnati,  Ohio,  45219,  United States
      Independence,  Ohio,  44131,  United States
Oregon
      Salem,  Oregon,  97309,  United States
      Portland,  Oregon,  97201,  United States
      Eugene,  Oregon,  97401,  United States
      Portland,  Oregon,  97209,  United States
Pennsylvania
      Philadelphia,  Pennsylvania,  19106,  United States
      Allentown,  Pennsylvania,  18104,  United States
      Philadelphia,  Pennsylvania,  19107,  United States
Rhode Island
      Lincoln,  Rhode Island,  02865-4208,  United States
Washington
      Seattle,  Washington,  98104,  United States
Wisconsin
      West Allis,  Wisconsin,  53227,  United States
      Milwaukee,  Wisconsin,  53226,  United States
      Madison,  Wisconsin,  53719,  United States
      Middleton,  Wisconsin,  53562,  United States
Canada, Alberta
      Edmonton,  Alberta,  T6G 2C8,  Canada
Canada, British Columbia
      Vancouver,  British Columbia,  V6Z 1Y6,  Canada
Canada, New Brunswick
      Miramichi,  New Brunswick,  E1V 3G5,  Canada
Canada, Nova Scotia
      Sydney,  Nova Scotia,  B1S 2E8,  Canada
Canada, Ontario
      Markham,  Ontario,  L6B 1A1,  Canada
      Mississauga,  Ontario,  L4W 1N2,  Canada
Canada, Quebec
      Hull,  Quebec,  J9A 1K7,  Canada

Study ID Numbers:  398149
Record last reviewed:  July 2004
Last Updated:  October 13, 2004
Record first received:  September 30, 2002
ClinicalTrials.gov Identifier:  NCT00046449
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08